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Comparison of Simulated High
Altitude Pilot Effective Performance
Time Between Habitual Smokers'
and Non-Smokers'
James F. Fletcher, Embry Riddle Aeronautical University, Daytona Beach, Florida
Smoking attenuates the amount of oxygen that diffuses from the lung tissue and oxygenates the
blood (Guyton, 1996). High altitudes attenuate the oxygen available for transport to the blood.
However, little has been reported on the combined effects of these two forms of hypoxia (inade-
quate oxygenation of the blood). It may be that, together, these two hypoxic conditions react
exponentially to critically affect human performance.
Fifty-two participants were screened for cotinine serum values >200 ng/dl- l , to flesh out nicotine
usage, through urine sampling. Nineteen participants were entered into the smoker's group and
33 into the non-smoker's group. All of the participants were active student pilots. All of them held
current instrument ratings and all of them had approximately the same amount of time and expe-
rience in instrument meteorological conditions (IMC).
Data were analyzed using Microsoft Excel and SPSS computer software statistic programs. The
criterion for significance (alpha) was set at 0.05. The test was a non-directional t-test (two-tailed),
which means that an effect in either direction was interpreted. Statistical significance existed when
comparing the mean effective performance times between smoking pilots and nonsmoking pilots
t = 3.541 (39), P = .05 in the experimental (simulated altitude) groups. Within the limitations of
this study it can be concluded that the combined hypoxic effects of smoking and high altitude
result in a statistically significant detriment in pilot effective performance time.
Smoking attenuates the amount of oxygen that diffuses from the lung tissue and oxy-
genates the blood (Guyton, 1996). High altitudes attenuate the oxygen available for
transport to the blood (poliler, 1971). However, little has been reported on the combined
effects of these two forms of hypoxia (inadequate oxygenation of the blood) (Nesthus,
Garner, Mills, 1997; Yoneda, Watanabe, 1997). It may be that together, these two
hypoxic conditions react exponentially to critically affect human performance. Such
may be the case for pilots who are chronic smokers' and are required to fly at high alti-
tudes to avoid severe weather or oncoming aircraft. The combined effects of low oxygen
content at high altitudes and reduced oxygen diffusion because of the smokers'
impaired ventilation efficiency, can significantly compromise pilot performance. This
possibility leads to the prediction that pilots who are chronic smokers' will evidence a
reduction in effective performance time when they fly at a simulated altitude of 10,000
feet mean sea-level (MSL) which has demonstrated a reduction in cognitive and motor
performance (Tune, 1964).
Pilot Effective Performance Time (PEPT)
Pilot effective performance time represents the time in seconds that a pilot takes to
maneuver an aircraft to maintain an assigned steady course of flight. During actual
flight, specific external environmental forces act upon the flight surfaces causing
changes in aircraft attitude. These conditions include changes in temperature lapse
rate, density altitude, wind velocity and atmospheric pressures. These changes may
cause the aircraft to unfavorably pitch (nose up or down), yaw (tail movement right or
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left), or roll (wing tips rise or fall). As these meteorological
phenomena occur, the pilot is required to respond skill-
fully, maneuvering the aircraft back to its assigned
course, heading, and altitude. Hence, the time required to
return the aircraft to the proper attitude is PEPT.
For this study, aircraft control, orientation, navigation,
and communication changes were simulated using a per-
sonal computer aviation-training device (PCATD). The
PCATD (Appendix A) used in this study was programmed
to simulate many of the atmospheric changes that may
occur during an actual flight.
In this study, PEPT was measured over a time window
of forty-five seconds, starting with the 40th minute of sim-
ulated flight time. Individual pilot PEPT recorded during
the 45-second window represents the total time it took the
participant to return to an assigned indicated altitude of
7,000 feet MSL (for visual reference) straight and level
flight without any adverse pitch, yaw, or roll. The
hypobaric chamber was used to simulate atmospheric
conditions at 3,049 meters (10,000 feet) MSL.
Physiological Principles of Oxygen
Transport
To appreciate the significance of the combined effects of
high altitude and chronic smokers" hypoxias, it is neces-
sary to make clear the physiological principles of oxygen
transport. Oxygen occupies about 21 % of the air we
breathe. When we inhale, oxygen makes its way to the alve-
oli of the lungs; it diffuses across the thin alveolar mem-
brane into the blood stream and crosses the membranes of
the arterial erythrocytes. The erythrocytes carry the oxy-
gen to the left side of the heart where it is pumped into the
body's systemic circulation and carried to awaiting tissue.
The tissue exchanges the oxygen for carbon dioxide and is
subsequently sent to the right side of the heart as venous
return via the inferior and superior vena cava.
Hemoglobin (Hb) is the principal transport system for
oxygen. The oxygen-hemoglobin dissociation curve dem-
onstrates, graphically, the progressive increase/decrease
in the percentage of hemoglobin bound with oxygen. As
the partial pressure of oxygen (P[02D increases, so too
does the percent saturation of hemoglobin.
Oxygen is fundamental for metabolic activity of the
cells in the body. This metabolism can be compromised
in an assortment of ways, including rapid or continuous
change in atmospheric pressures or the introduction or
ingestion of harmful gasses or materials. (Ernsting, 1988)
This compromise of the metabolic pathways makes
it difficult for cells to utilize oxygen that has diffused
across the membranes. This in turn forces the body to
compensate accordingly by increasing respiratory rate
and depth, as well as cardiac output. This condition of
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increased cardiopulmonary activity increases the rate at
which carbon dioxide is removed from the body. Paradoxi-
cally, carbon dioxide is important to stimulate respiration,
as it is necessary for converting carbonate, a base into
carbonic acid. Chemoreceptors in the dorsal medulla of the
brainstem continuously monitor pH levels. Decreased pH
enhances the neuronal firing rate of these cells, which in
turn increases respiratory rate and depth. Consequently,
decreased carbon dioxide content due to hyperventilation
results in decreased carbonic acid concentrations,
increased pH and a progressively weakened breathing sig-
nal. (Pitts, and Pace, 1947, DeHart, 2002).
Background
Only two studies could be found that investigated the
effects of chronic smoking and high altitude performance
(Nesthus, Garner, Mills, 1997; Yoneda and Watanabe,
1997). Both studies concluded that the smokers' per-
formed better in the early portion of 'the studies while both
cognitive and motor response rates deteriorated with pro-
longed exposure to high altitudes. The two studies dif-
fered in altitude exposures. Nesthus et al performed their
study at a simulated altitude of 8,000 feet MSL for a
period of two hours while the Yoneda [,. Wantanbe study
investigated responses at a simulated altitude of 25,000
feet MSL.
Denison, Ledewith, and Poulton (1966) and Ledewith
and Denison (1964) suggested their studies showed task
impairment at 8,000 feet. However, later studies have
been unable to demonstrate similar effects (Fowler, Paul,
Porlier, Elcombe, and Taylor, 1985; Crow and Kelman,
1971, 1973; Kelman and Crow, 1969; Kelman, Crow, and
Bursil, 1969). Eight thousand feet is the accepted maxi-
mum allowable cabin pressure on commercial jet aircraft.
The sparse literature that has reported the combined
effects of high altitude hypoxia (hypoxic) and chronic
smokers' hypoxia (hypemic) makes clear the need to
study the effects of simulated high altitude PEPT in smok-
ers' compared to non-smokers'.
The effects of altitude on the human body are
described in terms of atmospheric thermodynamics
(Appendix D). As a person ascends in altitude they pass
through "layers" or levels of the atmosphere. From sea
level to an altitude of about 91.5 km (300,000 ft.) the rela-
tive concentrations of atmospheric gases remains fairly
constant.
Nitrogen and oxygen are the most abundant gases;
78% and 21 % respectively. Compensatory physiological
changes occur continuously with changes in altitude. Gas
laws (Appendix C) that attempt to describe each and
every atmospheric condition in part, govern these physio-
logical changes. The greatest concentrations of work
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involving these gas laws were born in aviation with the
invention of the hot air or hot gas balloons.
The level where high altitude affects human perfor-
mance has been long in debate. Experiments performed
by the Federal Aviation Administration's (FAA) Civil Aero-
medical Institute demonstrated that exposure to a simu-
lated altitude of 12,500 feet caused decrements in
complex task performance (Mertens and Collins, 1986,
1985; Mertens McKenzie, Funkhouser, White and Milburn,
1982). Tune (1964) determined in his study that percep-
tual-motor performance degraded significantly at 10,000
feet. Some studies showed task impairment at 8,000 feet.
(Denison, Ledewith, and Poulton, 1966; and Ledewith and
Denison, 1964) However, later studies have been unable
to demonstrate similar effects (Fowler, Paul, Porlier,
Elcombe, and Taylor, 1985; Crow and Kelman, 1971,
1973; Kelman and Crow, 1969; Kelman, Crow, and Bursil,
1969). Eight thousand feet is the accepted maximum
allowable cabin pressure on commercial jet aircraft.
Rick Curtis (1999) labeled the atmospheric levels of alti-
tude as follows: high altitude (8,000 - 12,000 feet [2,438-
3,658 meters]), very high altitude (12,000 - 18,000 feet
[3,658 - 5,487 meters]), and extremely high altitude
(18,000 + feet [5,500+ meters]). The aviation community
has accepted 3,049 meters (10,000 feet) as the lowest
point on the altitude scale that hypoxia has noticeable
influence on cognitive and functional performance.
With ascent to altitude the atmospheric pressure
decreases, the partial pressure of oxygen becomes
increasingly reduced and the reduction in pressure results
in an extremely harsh environment, making survival
increasingly unlikely.
The atmosphere has been divided into three physiolog-
ical zones (physiological efficient zone, physiological defi-
cient zone, and space equivalent zone) in which human
survival eventually becomes dependent on specialized
equipment (pressurized aircraft, pressure suits, sealed
cabins/capsules, etc.).
Purpose of this Study
The purpose of this study is to investigate the com-
bined effects of high altitude hypoxia and chronic smok-
ers' hypoxia on PEPT. Questions that guided this study
are:
1. Is there a difference in smoker's PEPT at sea level
compared to non-smokers' PEPT at sea level?
2. Is there a difference between the smokers' PEPT at
sea level compared to their PEPT at a simulated alti-
tude of 3,049 meters (10,000 feet MSL)?
3. Is there a difference in non-smokers' PEPT at sea
level compared to their PEPT at a simulated altitude
of 3,049 meters (10,000 feet MSL)?
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ANOVA tests were applied to the captured data to
determine whether there was a difference in effective per-
formance times between smoking and nonsmoking pilots
at a simulated altitude of 3,049 meters (10,000 feet) and
sea level. Additional tests were applied to the data to com-
pare effective performance times for smoking pilots at
altitude and sea level and again with non-smoking pilots
at altitude and sea level.
Null Hypothesis
There is no statistical significant difference in pilot
effective performance time at an altitude of 3,049 meters
(10,000 feet MSL) in smokers' when compared to non-
smokers'.
Hypoxia and Smoking
Fowler and Kelso (1991) stated, "It is well known that
hypoxia increases visual reaction time." Evidence gath-
ered by Kobrick and Dusek (1970) and again by Fowler,
et al (1988) conducted studies in high altitude chambers.
These studies also found there was potential for barotrau-
mas due to the reduction of atmospheric pressures.
A reduced oxygen-breathing device (ROBD) involving
mixed gases and regulatory devices to induce hypoxic
effects were developed by Sausen, Wallick, Siobodnic,
Bower, and Clark (1999). Successful experiments per-
formed on U.S. Navy personnel using analytical tools to
determine cognitive assessment ranged from simple juve-
nile games to complex neuropsychological assessment
instruments, Le., selected memory instruments, math
problem solving, computerized tracking, and so on.
Original research conducted by Yoneda and Watanabe,
(1997) measured the response rates of pilots who were
habitual smokers' at an altitude of 7,620 meters
(25,000 ft). Their conclusions showed that smokers' were
slightly resistant to altitude hypoxia because of their affin-
ity toward anemic (hypemic) hypoxia brought about by
increased carboxyhemoglobin levels due to habitual
smoking. Most of the data gathered were considered sub-
jective. Observations included: warm sensation or heat
flush, thinking impairment, visual impairment, lethargy,
fatigue, dyspnea, sweating, tremor, anxiety headache,
euphoria, and nausea. However, the statistics were not
conclusive enough to determine long-term effects. In
addition, comparisons of habitual smokers' and non-
smokers" were not made at sea level. The study involved
only short duration exposure to high altitude. The most
frequently used profile for pilot and aircrew member train-
ing was a decompression of 25,000 ft. Mean Sea Level
(7,620m) for approximately 4-8 minutes with a hypoxia
experience and subsequent descent (U.S. Navy
Hypobaric Type II and Type IIa flight profiles). These
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profiles were used for investigating altitude tolerance
and hypoxia symptoms. Time of useful consciousness
(TUC) was determined with written instruments, hand-
writing samples, and simple numeric testing. Baseline
TUC was determined for both groups whether they
were smokers' or not. The research only made conclu-
sions regarding TUC and did not make statements
regarding PEPT.
Atmospheric Physics
The composition of the atmosphere is remarkably con-
stant between sea level and an altitude of 91. 5 km
(300,000 ft.). Nitrogen and oxygen are the most abundant
gases in the atmosphere. From a practical standpoint, in
studies concerning the effects of altitude on the human
body, the percent concentrations of the other gases are
considered negligible and are ignored. Air has an approxi-
mate composition of 78% nitrogen and 21 % oxygen by
volume, which is directly affected by temperature and
pressure. The measure of dry air at sea level is usually
seen defined by its mass (mmHg). The region of the
atmosphere to which humans are adapted physiologically
extends from sea level to 3,049 m (10,000 feet). The oxy-
gen level within this zone is sufficient to keep a normal,
healthy person physiologically fit without the aid of spe-
cial protective equipment. The changes in pressure
encountered with rapid ascents or descents within this
zone can produce ear or sinus difficulties.
A physiologically deficient region extends from
3,049 m to about 15.3 km. Because of reduced atmo-
spheric pressure, this is the zone in which oxygen defi-
ciency becomes an ever-increasing problem.
Supplemental oxygen is required when flying above
3,811 m (12,500 feet) (FAR 91.211). Trapped gas in
the intestinal tract and evolved gas problems occur
within this zone. [n addition, protection must be pro-
vided against decreasing temperature.
The space-equivalent region begins when 50,000
feet is reached since supplemental oxygen (100%),
even when supplied under pressure, no longer protects
one from the problem of hypoxia. The means of pro-
tecting a person above 50,000 feet are such that they
will also offer protection in true space (Le., pressure
suits, sealed cabins). The only additional physiological
problems occurring within this zone, which extends
from 50,000 feet to 120 miles, are possible radiation
effects and the boiling of body fluids in an unprotected
individual. Boiling of body fluids will occur when the
total barometric pressure is less than the vapor pres-
sure of water at 370C (47 mmHg), which is reached at
19.6 km (63,500 feet, Armstrong Line) (Boothby, Love-
[ace, Benson, & Strehler, 1954).
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Physiological Requirements of Oxygen
The periodic and rhythmic characteristics of respira-
tion are maintained by means of comparatively clear ner-
vous pathways between the lungs and respiratory
muscles and the brain. The medulla oblongata is the loca-
tion for neural control of respiration. Within the compact,
definitively located segment of the medulla is the respira-
tory center. There are two distinct aggregations of nerve
cells. These are the inspiratory and expiratory centers. [t
is believed that the inspiratory center is located caudal to
the expiratory center. Specialized nerve cells are located
in the pons, which also influence respiratory activity. This
higher center is sometimes referred to as the pneumot-
axic center (Fisher, 1991).
Ventilation is a cyclic process by which fresh air or a
gas mixture enters the lungs and pulmonary air is
expelled. The inspired volume is greater than the expired
volume because the volume of oxygen absorbed by the
blood is greater than the volume of carbon dioxide, which
is released from the blood. Since gas exchange occurs
solely in the alveoli and not in the conducting airways, the
estimation of alveolar ventilation rate (Le. the amount of
gas which enters the alveoli per minute) is the single most
important variable of ventilation (Guyton & Hall, 2000).
Oxygenation of the tissue yields the metabolic conver-
sion of oxygen to carbon dioxide. Carbon dioxide (C02) is
exchanged for oxygen at the cellular level and is con-
verted to carbonic acid (H2C03). The direct effects of CO2
on the respiratory centers produce a [ower signal fre-
quency than oxygen, which triggers an autonomic
response reminding the body to breathe. These responses
at the pneumotaxic center have a lesser effect than the
peripheral chemoreceptors. This would indicate that the
peripheral chemoreceptors receive and transmit signals
to the respiratory center before blood containing carbonic
acid reaches the pneumotaxic center. The respiratory
center is also sensitive to low pH levels (acidity) caused by
rising carbonic acid levels. Both low oxygen levels and
acidic pH levels cause the brain to increase both the rate
and depth of breathing which, in turn, increases the
amount of oxygen available to the body. Unfortunately,
increased depth and rate of breathing also causes the
body to expel CO2 at an increased rate. As a result, there
is rapid loss of carbonic acid, which again is an important
breathing stimulus for the brain (Ernsting, 1988).
Metabolism of Smoking
Nicotine is rapidly metabolized and has a short half-life;
cotinine, the major metabolite of nicotine, is metabolized
and eliminated at a much [ower rate. Because of the
resulting increase with time in the cotinine to nicotine
ratio in the body, including in the brain, it is of interest to
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examine the effect of cotinine on nicotine-induced
changes (Sziraki, Sershen, Benuck, Lipovac, Hashim,
Cooper, Allen, Lajtha, Nathan, Kline, 1999).
Because cotinine is a major metabolite of nicotine it is
currently regarded as the best biomarker for exposure to
tobacco. Cotinine measurement is preferred over measur-
ing nicotine because its retention in the body is much
longer than nicotine. Cotinine can be measured in blood
(Le., in serum), urine, saliva, and hair. Nonsmokers'
exposed to typical levels of environmental tobacco
smoke (ETS) have cotinine levels less than 1 nanogram
per milliliter (ngjmL), with heavy exposure to ETS pro-
ducing levels in the 1 to 15-ngjmL ranges. Active smok-
ers' almost always have levels higher than 15 ngjmL,
sometimes over 500 ngjmL (Pirkle, Flegal, Bernert,
Brody, Etzel, Maurer, 1996).
Cotinine Immunoassays
The assay chosen to determine which participants
were cigarette users in this study was the Sure Step ™
smoke check test. This test was a lateral flow, one-step
immunoassay for the qualitative detection of cotinine, the
major metabolite of nicotine in human urine, at a cutoff
concentration of 200 ngjdl- l . This product was used to
obtain visual, qualitative results and was intended to pro-
vide objective means to determine the chronic smokers'
from the non-smokers'.
Findings and Discussion
Smokers·vs. Non-smokers' Pilot Effective
Performance Time at High Altitude
An independent samples t-test that compared the
mean smokers' (n = 19), PEPT at 3,049 meters (10,000
feet MSL) to the non-smokers' (n=33) PEPT at 3,049
meters (10,000 feet MSL) revealed that the smokers'
PEPT was 17.0356 seconds, Table 4, and the mean non-
smokers' PEPT was 15.0870 seconds, Table 6. The com-
puted t (df) between these two means was 3.541 (df=51),
which was significant at the .001 level. These results show
that the smokers' pilot effective performance time was
longer than the non-smokers" PEPT. These results reject
the null hypothesis that there was no difference in pilot
effective performance time at high altitude between
smokers' and non-smokers'. These findings suggest that
the combined altitude and smoking hypoxias were signifi-
cantly more detrimental to pilot performance skills
required to maintain the assigned altitude of 7,000 feet
MSL than high altitude hypoxia alone.
Table 1 Independent samples t test to compare the means of pilot effective performance times.
Smokers' and nonsmokers' N Mean time (sec) t (df) P
Pilot performance at altitude-smoker 1933 17.3056 3.541 (51) .001
nonsmoker 15.0870
Pilot performance at sea level-smoker 19 10.6389 -1.538(51 ) .132
nonsmoker 33 12.9348
Table 2 Paired samples t test comparing smoker pilot effective performance time at altitude and sea level.
Independent Variable Mean Std. Dev Std.Er. t (df) P
Smoker performance time at altitude 17.3056 3.80069 .89583 -6.624(18) .000
Smoker performance time at sea level 10.6398 5.59886 1.31966
Table 3 Paired samples t test comparing non-smoking pilot effective performance time at altitude and sea level.
Independent Variable Mean Std. Dev Std.Er. t (df) p
Nonsmoker performance time at altitude 15.0870 5.6421 1.1765 2.827 (32) .010
Nonsmoker performance time at sea level 12.9348 3.9580 .825
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This objective evidence agrees with original research
conducted by Yoneda and Watanabe (1997). They mea-
sured response rates of pilots who were habitual smok-
ers', at an altitude of 25,000 feet MSL. They concluded
that smokers' were slightly resistant to altitude hypoxia
because of their affinity toward hypemic hypoxia brought
about by the increase of carboxyhemoglobin levels due to
habitual smoking. Their data was based on subjective
observations, e.g. warm sensations, visual and thinking
impairment, fatigue, and headaches. Never the less, their
subjective data support the findings of the present study.
Smokers'vs. Non-smokers' PEPT at Sea Level
An independent samples t-test compared the mean
smokers' (n = 19) at sea level to the mean of the non-
smokers" (n = 33) at sea level. The respective pilot effec-
tive performance times were 10.6398 seconds for the
smokers' and 12.9348 seconds for the non-smokers',
Table 4. The computed t(df) between the two means was
1.538 (n = 51). It was not significant (p = .132). These
results show there was not a difference in the pilot effec-
tive performance time at sea level between the smokers'
and non-smokers'. These data suggest that smoking
hypoxia alone is not sufficiently detrimental to pilot effec-
tive performance skills required to maintain the assigned
navigational course at sea level. These findings answer
question number one of the related questions proposed to
guide this study: Is there a difference between smokers'
PEPT at sea level compared to the non-smokers' pilot
effective performance time at sea level? The answer is no.
Smokers' Pilot Effective Performance Time at 3,049
meters (10,000 feet MSL) vs. Sea Level
A paired samples t-test compared smoker effective per-
formance time at high altitude and sea level (Table 5).
The mean pilot effective performance time at altitude
(17.3056 seconds) was significantly greater than their
pilot effective performance time at sea level (10.6398 sec-
onds). This difference was significant at the 0.000 level.
These data suggest that high altitude hypoxia, by itself;
can cause significant attenuation of PEPT. And that only
when smokers' fly at high altitudes and experience the
effects of high altitude hypoxia is PEPT significantly
affected. These findings answer question number two of
the related questions guiding this study: Is there a differ-
ence in the smokers" pilot effective performance time at
sea level compared to high altitude? The answer is yes.
Non-Smokers' Pilot Effective Performance Time at
High Altitude vs. Sea Level
A paired samples t-test compared the non-smokers"
PEPT at 3,049 meters (10,000 feet MSL) and sea level
(Table 6). The mean pilot effective performance time at
3,049 meters (10,000 feet MSL) (15.08 seconds) was sig-
nificantly greater than their PEPT at sea level (12.9348
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seconds). This difference was significant at the 0.01 level.
These data suggest that high altitude hypoxia, by itself; can
cause a significant attenuation of PEPT. These data answer
the question number three of the related questions guiding
the study: Is there a difference in the non-smokers" PEPT
at sea level compared to high altitude? The answer is yes.
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